JAK2 kinase domain mutations confer resistance to JAK inhibitors in a pro-B cell model of a high-risk acute lymphoblastic leukaemia

Charlotte EJ Downes
, Barbara J McClure
, John B Bruning
, Susan L Heatley
, Chung H. Kok
, Timothy P. Hughes
, David T Yeung
, Deborah L White

Research output: Contribution to conference › Poster

1 results

2021
Acquired JAK2 mutations confer resistance to JAK inhibitors in cell models of acute lymphoblastic leukemia
Downes, C. E. J., McClure, B. J., Bruning, J. B., Page, E., Breen, J., Rehn, J., Yeung, D. T. & White, D. L., 10 Aug 2021, In: npj Precision Oncology. 5, 13 p., 75.
Research output: Contribution to journal › Article › peer-review

Open Access
File
21 Citations (Scopus)

65 Downloads (Pure)